Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation - Wikidata - wikimedia - TriplyDB

Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation

Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation

http://www.wikidata.org/entity/Q36941132

about

Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28 Progress toward curing HIV infections with hematopoietic stem cell transplantation.Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients After HLA-Matched Allogeneic Stem Cell Transplantation Unraveling graft-versus-host disease and graft-versus-leukemia responses using TCR Vβ spectratype analysis in a murine bone marrow transplantation model.Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease New perspectives on the biology of acute GVHD.TRBV kinetics and its association with HLA disparity and aGVHD following allogeneic hematopoietic stem cell transplantation.

P2860

Q34122445-CD871F28-2C2B-4583-B43E-1F8C509E392A Q34974480-A0A40DDF-1E40-428A-A225-EB28A29777D4 Q35588845-0586D83C-9A13-4B8B-AFED-5259E5D762ED Q36302494-849D4729-21E4-4035-87ED-4E5E4D5762BE Q36487595-A6A4DB74-2761-4705-83B8-672FDDC5887F Q37104281-2DB04162-9E13-4609-925A-0A205414048A Q37383856-7DE6081B-6FEA-4217-BDE9-9A4CA2B080B8 Q37479204-55463FD4-A19C-4E1F-BF0F-59C385CBDF0D Q37641063-FC3F7734-D9B2-44B4-B150-BE399F93579C Q43874049-3585A602-638A-4494-B20F-F609937E2767

P2860

Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation

http://www.wikidata.org/entity/Q36941132

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Overlap between in vitro donor ...... ood and marrow transplantation

@en

type

label

Overlap between in vitro donor ...... ood and marrow transplantation

@en

prefLabel

Overlap between in vitro donor ...... ood and marrow transplantation

@en

P1433

Q36941132-FD3945DB-4900-4DFF-AC8F-1C1C6974EE8D

P1476

Q36941132-41786D6C-30E2-4553-A7C8-A2998A3C948D

P2093

Q36941132-198E28B2-0FFB-45BB-9731-4F353A9A50D3

Q36941132-422EEA40-860F-40E4-87CB-A71B968173FA

Q36941132-42D54261-55EA-496C-B3D7-63A778AAF4A5

Q36941132-90C65CC6-37B8-4848-90FE-1BF5749D6331

Q36941132-9ACF82A3-71A4-4725-A903-F9BBB8A0FDC5

Q36941132-9C5B89AB-EFDB-4220-84C3-E18F0EADBE16

Q36941132-DEEC8D49-D90B-45B3-9E68-5BC23EE69FC7

Q36941132-E460D382-B413-416A-B2A3-4E429F659E22

Q36941132-F015A2A0-6028-4EE6-9A26-7241341BD4B9

P2860

Q36941132-12EC8001-A2D9-44D2-BCA2-8CF93A43E85F

Q36941132-132ADFC3-F0C9-45F0-B63C-397D4E98B308

Q36941132-16367102-751B-4938-9437-E7602C4BC54A

Q36941132-1DD3EE36-B450-495D-87F0-80FE94C8430C

Q36941132-246CE644-214B-494E-8256-5214010A528B

Q36941132-26393D30-7869-48FB-A5ED-4DAD23D93192

Q36941132-40E5A0A0-3FEB-42F2-861A-A0696CEB91B7

Q36941132-41E42666-33EA-4334-AB11-1284D786D974

Q36941132-4306A074-5132-4A7A-AC7D-66DA15B304C7

Q36941132-5E60095B-2A34-4664-8384-2D7314C28473

P304

Q36941132-92167785-345C-4244-A45D-C8083F571ED1

P31

Q36941132-9A10CE60-0746-4437-B929-CA06C0E4F49A

P356

Q36941132-DED8FA2E-8ED4-4458-AC26-D423FB2A204C

P407

Q36941132-32AD9273-13C3-4989-86F7-1DF81244CB81

P433

Q36941132-F302F2C9-56B6-452C-BE08-8DC374007464

P478

Q36941132-A2D620D1-861C-4BBA-99D6-F53312C7A406

P577

Q36941132-CB2A03C4-3BBD-4889-A3FE-ED079F918C57

P5875

Q36941132-1FF083E0-05D7-4368-8415-55373A0D9F12

P698

Q36941132-40C505BF-9E55-4A89-AB00-DAB9495C4358

P932

Q36941132-59EEFEC5-24BB-45A0-9CCD-7442AC3FACD1

P356

BLOOD-2008-03-145391

P1433

P1476

Overlap between in vitro donor ...... ood and marrow transplantation

@en

P2093

Jenny Zilberberg

http://www.w3.org/2001/XMLSchema#string

Joanne Filicko-O'Hara

http://www.w3.org/2001/XMLSchema#string

Kira Goldgirsh

http://www.w3.org/2001/XMLSchema#string

Michele Donato

http://www.w3.org/2001/XMLSchema#string

Neal Flomenberg

http://www.w3.org/2001/XMLSchema#string

Robert Korngold

http://www.w3.org/2001/XMLSchema#string

Scott D Rowley

http://www.w3.org/2001/XMLSchema#string

Stephanie A Berger

http://www.w3.org/2001/XMLSchema#string

Thea M Friedman

http://www.w3.org/2001/XMLSchema#string

P2860

The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.

The role of interleukin-12 and interferon-gamma in GVHD and GVL.

Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy.

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation

Graft-versus-lymphoma effects: clinical review, policy proposals, and immunobiology.

Stem cell transplantation: graft-mediated antileukemia effects.

Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.

T-cell receptor Valpha spectratype analysis of a CD4-mediated T-cell response against minor histocompatibility antigens involved in severe graft-versus-host disease.

Graft-versus-leukemia following bone marrow transplantation.

P304

3517-3525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-03-145391

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5315131

http://www.w3.org/2001/XMLSchema#string

P698

18541718

http://www.w3.org/2001/XMLSchema#string

P932

2569187

http://www.w3.org/2001/XMLSchema#string